ITGAX and melanoma: Recent reports showed that incorporating GM-CSF, CpG and tumor antigens in PLG matrices efficiently attracted and stimulated both conventional DC (CD11c + CD11b + and CD11c + CD8a+) and plasmacytoid DC, resulting in superior immune responses (Th1 and CTL) against B16 melanomas in mice [29, 30].